Published in AIDS on January 01, 1997
Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nat Rev Neurol (2010) 2.48
Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis (2009) 1.82
Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev (2004) 1.42
AIDS mortality in a tertiary health institution: A four-year review. J Natl Med Assoc (2006) 1.22
Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol (2010) 1.17
PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS. J Clin Invest (2004) 1.15
A moment closure model for sexually transmitted disease transmission through a concurrent partnership network. Proc Biol Sci (2000) 1.13
Reevaluating and optimizing polyomavirus BK and JC real-time PCR assays to detect rare sequence polymorphisms. J Clin Microbiol (2011) 1.04
Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate. Ann Neurol (2015) 0.99
Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders. J Clin Microbiol (2000) 0.99
Comparison of three nucleic acid amplification assays of cerebrospinal fluid for diagnosis of cytomegalovirus encephalitis. J Clin Microbiol (2001) 0.93
Longitudinal analysis of activation markers on monocyte subsets during the development of simian immunodeficiency virus encephalitis. J Neuroimmunol (2006) 0.92
The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds to activated and infected brain macrophages in areas of synaptic degeneration: implications for PET imaging of neuroinflammation in lentiviral encephalitis. Neurobiol Dis (2007) 0.92
Immune surveillance and response to JC virus infection and PML. J Neurovirol (2013) 0.91
Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era. Eur J Clin Microbiol Infect Dis (2013) 0.90
Arboprotozoae. Transfus Med Hemother (2009) 0.86
Neurological complications of transplantation: part I: hematopoietic cell transplantation. Neurohospitalist (2013) 0.84
Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy. J Clin Microbiol (1999) 0.82
Application of molecular diagnostic techniques for viral testing. Open Virol J (2012) 0.81
Frequent detection of Epstein-Barr Virus and cytomegalovirus but not JC virus DNA in cerebrospinal fluid samples from human immunodeficiency virus-infected patients in northern Thailand. J Clin Microbiol (2005) 0.81
Diffusion-weighted imaging in patients with progressive multifocal leukoencephalopathy. Eur Radiol (2008) 0.79
Cerebral toxoplasmosis mimicking subacute meningitis in HIV-infected patients; a cohort study from Indonesia. PLoS Negl Trop Dis (2013) 0.79
Rapidly progressive cerebellar ataxia in West Wales. BMJ Case Rep (2013) 0.79
Critical care of persons infected with the human immunodeficiency virus. Clin Chest Med (2013) 0.79
Young-onset dementia. Semin Neurol (2013) 0.79
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? Clin Dev Immunol (2013) 0.78
Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy. Rev Med Virol (2015) 0.76
Progressive multifocal leukoencephalopathy presenting as IRIS in an AIDS patient. A case report and literature review. Neuroradiol J (2013) 0.76
A cerebellar tremor in a patient with human immunodeficiency virus-1 associated with progressive multifocal leukoencephalopathy. J Mov Disord (2009) 0.75
Toxoplasmic Encephalitis with Untreated Hairy Cell Leukemia Variant. Intern Med (2016) 0.75
Bendamustine associated with irreversible ascending paralysis. Case Rep Hematol (2013) 0.75
Survival of an AIDS patient after infection with Acanthamoeba sp. of the central nervous system. Infection (2017) 0.75
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med (1995) 3.89
A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med (1995) 3.30
Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (2000) 3.13
The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: a study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission. Epidemiology (1994) 3.05
Rapid viral diagnosis of acute respiratory infections: comparison of enzyme-linked immunosorbent assay and the immunofluorescence technique for detection of viral antigens in nasopharyngeal secretions. J Clin Microbiol (1985) 2.69
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study. Arch Intern Med (2000) 2.49
Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood (2001) 2.37
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A (1997) 2.24
A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med (1991) 2.10
Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol (2005) 2.04
The whereabouts of a morphogen: direct evidence for short- and graded long-range activity of hedgehog signaling peptides. Dev Biol (2001) 1.98
Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction. J Infect Dis (1992) 1.90
Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Ann Neurol (1991) 1.84
Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol (1987) 1.81
Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis (1997) 1.79
Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy. Proc Natl Acad Sci U S A (2000) 1.73
Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission. Arch Intern Med (1994) 1.72
Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS (1998) 1.70
Biomarkers of HIV-1 CNS infection and injury. Neurology (2007) 1.69
Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet (1993) 1.68
Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection. J Infect Dis (2000) 1.66
Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J Clin Invest (1993) 1.64
Healing of bone defects by guided tissue regeneration. Plast Reconstr Surg (1988) 1.63
Screening plate method for detection of bacterial beta-glucuronidase. Appl Microbiol (1973) 1.61
A case of diffuse leptomeningeal oligodendrogliomatosis associated with HHV-6 variant A. Neuropediatrics (2002) 1.59
Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis. Clin Exp Immunol (1985) 1.57
How many HIV-infected individuals may be defined as long-term nonprogressors? A report from the Italian Seroconversion Study. Italian Seroconversion Study Group (ISS) J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.57
Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections. J Clin Microbiol (1984) 1.53
Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. J Med Virol (1987) 1.52
Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results. North American Linomide Investigators. Neurology (2000) 1.52
Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS. AIDS in Europe Study Group. Clin Infect Dis (1995) 1.51
Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study. Am J Epidemiol (1992) 1.46
Cutaneous infection caused by Mycobacterium gordonae in a human immunodeficiency virus-infected patient receiving antimycobacterial treatment. Clin Infect Dis (1997) 1.46
Sequence variation within three important cytomegalovirus gene regions in isolates from four different patient populations. J Clin Microbiol (1998) 1.43
Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. Blood (1997) 1.41
The watermelon stomach: clinical, endoscopic, endosonographic, and therapeutic aspects in three cases. Endoscopy (1995) 1.40
Chronic infectious mononucleosis; a case report. J Intern Med (1989) 1.40
Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis. Arch Neurol (2001) 1.40
Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood (1998) 1.39
Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy. Neurology (2000) 1.39
Epstein-Barr virus induced thrombocytopenia treated with intravenous acyclovir and immunoglobulin. Scand J Infect Dis (1989) 1.39
[Cerebrospinal fluid diagnosis using polymerase chain reaction]. Ned Tijdschr Geneeskd (1996) 1.38
Epidemic Kaposi's sarcoma in Italy, a country with intravenous drug abusers as the major group at risk for AIDS: report of 60 cases. AIDS (1989) 1.38
Nested polymerase chain reaction for diagnosis and monitoring treatment response in AIDS patients with tuberculous meningitis. AIDS (1995) 1.37
Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome. Clin Exp Immunol (1986) 1.37
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival. J Acquir Immune Defic Syndr (1999) 1.35
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS. Neurology (2005) 1.33
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts. Infection (2009) 1.33
Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients. J Clin Microbiol (1997) 1.31
HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet (1986) 1.31
Evaluation of PCR in detection of Mycobacterium tuberculosis from formalin-fixed, paraffin-embedded tissues: comparison of four amplification assays. J Clin Microbiol (1998) 1.30
TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS (1994) 1.29
Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele. J Exp Med (1997) 1.28
CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro. J Immunol (2000) 1.28
Evaluation of three commercial enzyme-linked immunosorbent assays and two latex agglutination assays for diagnosis of primary Epstein-Barr virus infection. J Clin Microbiol (1997) 1.28
Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis (2001) 1.28
Ca2+-binding studies of the phosphoprotein from rat-incisor dentine. Eur J Biochem (1981) 1.28
Case-control study on concentrations of organohalogen compounds and titers of antibodies to Epstein-Barr virus antigens in the etiology of non-Hodgkin lymphoma. Leuk Lymphoma (2001) 1.27
HIV seroprevalence among 304 female prostitutes from four Italian towns. AIDS (1989) 1.27
The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy. J Neurovirol (2001) 1.26
Nonocollagenous proteins of dentin. Isolation and partial characterization of rat dentin proteins and proteoglycans using a three-step preparative method. Coll Relat Res (1981) 1.26
Noncollagenous proteins of dentin. A re-examination of proteins from rat incisor dentin utilizing techniques to avoid artifacts. J Biol Chem (1980) 1.26
Circulating epstein-barr virus in children living in malaria-endemic areas. Scand J Immunol (2005) 1.25
Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection? Clin Infect Dis (1997) 1.24
Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin Exp Immunol (1985) 1.24
Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation. Bone Marrow Transplant (1999) 1.23
Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. J Infect Dis (1986) 1.22
Epidemiology of cryptosporidiosis among European AIDS patients. Genitourin Med (1996) 1.20
Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid. J Infect Dis (1992) 1.20
Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma. J Clin Microbiol (2001) 1.20
TRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence results. HIV Med (2003) 1.20
AIDS-defining diseases in 250 HIV-infected patients; a comparative study of clinical and autopsy diagnoses. AIDS (1992) 1.20
Dental fear and avoidance: a comparison of two modes of treatment. J Dent Res (1984) 1.19
Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. AIDS (1998) 1.19
Comparative evaluation of nine kits for rapid diagnosis of infectious mononucleosis and Epstein-Barr virus-specific serology. J Clin Microbiol (1994) 1.19
JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.19
Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts. J Immunol (2000) 1.18
Cytomegalovirus DNA detection of an immediate early protein gene with nested primer oligonucleotides. J Virol Methods (1991) 1.18
Replication of hepatitis C virus in B lymphocytes (CD19+) Blood (1999) 1.18
Constitutive activation of STATs upon in vivo human immunodeficiency virus infection. Blood (1999) 1.17
Nested PCR for detection of BK virus and JC virus DNA. Clin Diagn Virol (1994) 1.17
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. Antimicrob Agents Chemother (1992) 1.15